← back to database
New Science Ventures backs life sciences and information technology companies by funding early and late-stage startups with breakthrough science. The firm invests across pharmaceuticals, biologics, medical devices, diagnostics, semiconductors, software, AI, data analytics, and IoT, emphasizing IP protection and differentiated value propositions. It provides strategic guidance to build management teams and steer companies toward value inflection points. Headquartered in Connecticut with an office in London, NSV focuses on global markets and science-based innovations.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Somu SubramaniamManaging Partner
- Tom LavinPartner
- Jean-Pierre BizetPartner and Senior Advisor
- Andrew AbramsPartner